Riskpilot← Back to searchSign inGet full accessLimbus Oy
OYDissolvedY-tunnus 2516563-7Kolmipolku 2Medical specialists activities · NACE 8622Est. 2012— employees
Revenue 2025
EUR 471K
-1% vs 2024
EBITDA margin
25.3%
+123% vs 2024
Equity ratio
96.6%
Financial strength
Net profit 2025
EUR 116K
+67% vs 2024
| Revenue | EUR 471K | -1% |
| EBITDA | EUR 119K | +123% |
| Net profit | EUR 116K | +67% |
| Total assets | EUR 768K | +5% |
| Equity | EUR 741K | +9% |
| Employees | — | — |
Legal name
Limbus Oy
Y-tunnus number
2516563-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
4. joulukuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Kolmipolku 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 404 | 329 | 477 | 476 | 471 |
| Staff expenses | −220 | −178 | −311 | −305 | −244 |
| EBITDA | 92 | 71 | 44 | 54 | 119 |
| Depreciation & amort. | −19 | −14 | −11 | −8 | −13 |
| EBIT | 73 | 57 | 33 | 46 | 106 |
| Net financials | −1 | 4 | 52 | 33 | 31 |
| Profit before tax | 72 | 61 | 85 | 79 | 137 |
| Tax | 14 | 12 | 5 | 9 | −21 |
| Net profit | 58 | 49 | 80 | 70 | 116 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 745 | 698 | 740 | 730 | 768 |
| Equity | 635 | 633 | 662 | 679 | 741 |
| Long-term debt | 51 | 33 | 16 | 4 | 2 |
| Short-term debt | 59 | 32 | 62 | 47 | 24 |
| Total debt | 110 | 65 | 78 | 51 | 26 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20212025
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20212025
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
KI Chief Executive Officer | Chief Executive Officer | 2012 |
MJ Deputy Member | Deputy Member | 2024 |
JA | Audit | 2024 |
KK Deputy auditor | Deputy auditor | 2024 |
| Former (1) | ||
NP | Audit | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Limbus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kimmo Ilmari Koskela | Chief Executive Officer | 0 companies |
| Marjo Johanna Koskela | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Niina Pauliina Lettojärvi | Audit | 0 companies |
| Kiri Kasperi Sopanen | Deputy auditor | 0 companies |
| Kristiina Johanna Maria Seppälä | Board of Directors | 0 companies |